Patent Issued to Medical Technology and Innovations, Inc. For Female Incontinence Control Device; Company Plans Worldwide Launch of Its Steridyne IVD Shortly.

Business Editors/Health & Medical Writers

LANCASTER, Pa.--(BW HealthWire)--April 30, 2002

Medical Technology & Innovations, Inc. (MTI) (OTCBB:MTIV.OB) the Company known for innovative medical devices and products, announced today that it has been issued a United States Letters Design Patent No. D455,488S, which issued on April 9, 2002 for Female Incontinence Control Device.

Mr. Jeremy P. Feakins, Chairman and Chief Executive Officer, said: "We are thrilled that we have been awarded a Patent for our new Female Incontinence Control Device. The Patent is one more step towards our worldwide launch of the device, which is named `Steridyne IVD(TM).'"

Mr. Larry James PA, Senior Vice President of Research and Development commented: "Our new Female Incontinence Control Device, `Steridyne IVD(TM),' has taken us several years to develop. Receiving this Patent provides us with the necessary proprietary technology protection. Steridyne IVD is a world-class device that promises relief to millions of women worldwide who suffer from Female Urinary Stress Incontinence. In the USA alone, more than 12 million women suffer from Urinary Incontinence. Our new patented device, Steridyne IVD(TM) will offer to these women a control device that offers a simple, hygienic and non-surgical solution."

MTI recently reported on the 100% successful outcome of medical trials conducted by Dr. Felecia Froe, Director, UroCare For Women, LLC based in Kansas City, MO.

Dr. Froe reported: "The Urinary Incontinence Device developed by Medical Technology & Innovations, shows tremendous promise as a solution for women with incontinence. The device will be a much needed solution for women everywhere who suffer from this problem."

About MTI

MTI is a growth stage company that has developed proven technology. It is the developer and manufacturer of the PhotoScreener(TM), a patented first-to-market device that can screen preverbal children and others for signs of serious eye conditions before irreversible problems occur. MTI has developed Steridyne IVD(TM), a patented female urinary incontinence control device.

Steridyne IVD has completed pre-market testing and is expected to be launched shortly. Steridyne Corporation, a wholly owned subsidiary of MTI is a developer, manufacturer and importer of a wide range of health care products to the consumer, professional and ethical markets.

Note: This News Release contains certain "forward-looking statements as such term is defined in the Private Securities Litigation Reform Act of 1995 and information relating to the Company are based on the beliefs of the Company's management as well as assumptions made by and information currently available to the Company's management.

Such statements reflect the current risks, uncertainties and assumptions related to certain factors including, without limitations, competitive factors, general economic conditions, customer relations, relationships with vendors, the interest rate environment, governmental regulation and supervision, seasonality, distribution networks, product introductions and acceptance, technological change, changes in industry practices, and one-time events.

Should any one or more of these risks or uncertainties materialize, or should any underlying assumptions prove incorrect, actual results may vary materially from those described herein.